Cellectis Reports Third Quarter and First Nine Months 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Cellectis (CLLS) Misses Q2 EPS by 5c
November 16, 2015 5:02 PM ESTCellectis (NASDAQ: CLLS) reported Q2 EPS of (EUR0.36), EUR0.05 worse than the analyst estimate of (EUR0.31). Revenue for the quarter came in at EUR1 million versus the consensus estimate of EUR5.6 million.
As of September 30, 2015 Cellectis had 279.4 million in cash and cash equivalents compared to... More
